Dichloroacetate causes reversible demyelination in vitro: potential mechanism for its neuropathic effect
Authors:
- 2 October 2006
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 100 (2) , 429-436
Abstract
Dichloroacetate (DCA) is an investigational drug for genetic mitochondrial diseases whose use has been mitigated by reversible peripheral neuropathy. We investigated the mechanism of DCA neurotoxicity using cultured rat Schwann cells (SCs) and dorsal root ganglia (DRG) neurons. Myelinating SC‐DRG neuron co‐cultures, isolated SCs and DRG neurons were exposed to 1–20 mm DCA for up to 12 days. In myelinating co‐cultures, DCA caused a dose‐ and exposure‐dependent decrease of myelination, as determined by immunolabeling and immunoblotting for myelin basic protein (MBP), protein zero (P0), myelin‐associated glycoprotein (MAG) and peripheral myelin protein 22 (PMP22). Partial recovery of myelination occurred following a 10‐day washout of DCA. DCA did not affect the steady‐state levels of intermediate filament proteins, but promoted the formation of anti‐neurofilament antibody reactive whirls. In isolated SC cultures, DCA decreased the expression of P0 and PMP22, while it increased the levels of p75NTR (neurotrophin receptor), as compared with non‐DCA‐treated samples. DCA had modest adverse effects on neuronal and glial cell vitality, as determined by the release of lactate dehydrogenase. These results demonstrate that DCA induces a reversible inhibition of myelin‐related proteins that may account, at least in part, for its clinical peripheral neuropathic effects.Keywords
This publication has 28 references indexed in Scilit:
- Mechanism and age dependence of dichloroacetate-induced peripheral neuropathyMitochondrion, 2006
- Controlled Clinical Trial of Dichloroacetate for Treatment of Congenital Lactic Acidosis in ChildrenPediatrics, 2006
- Aggregate formation and phosphorylation of neurofilament-L Pro22 Charcot–Marie–Tooth disease mutantsHuman Molecular Genetics, 2006
- In vitro cytotoxicity assays: Comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chlorideToxicology Letters, 2006
- Chronic treatment of mitochondrial disease patients with dichloroacetateMolecular Genetics and Metabolism, 2004
- Behavioral Evaluation of the Neurotoxicity Produced by Dichloroacetic Acid in Rats11Portions of this research were presented at the annual Society of Toxicology meeting (The Toxiologist 13:252; 1993) and at the ILSI Workshop on Disinfection By-Products, 1995.Neurotoxicology and Teratology, 1999
- Therapy of complex I deficiency: Peripheral neuropathy during dichloroacetate therapyEuropean Journal of Pediatrics, 1995
- Axonal regulation of Schwann cell integrin expression suggests a role for alpha 6 beta 4 in myelination.Journal of Cell Biology, 1993
- 90-Day toxicity study of dichloroacetate in dogs*1Fundamental and Applied Toxicology, 1991
- Ninety day toxicity study of chloroacetic acids in ratsFundamental and Applied Toxicology, 1991